Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan

Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan

Although vaccines would be the ideal tool for control, prevention, elimination, and eradication of many infectious diseases, developing of parasites vaccines such as malaria vaccine is very complex. The most advanced malaria vaccine candidate RTS,S, a pre-erythrocytic vaccine, has been recommended f...

Full description

Bibliographic Details
Main Authors: Shima Mahmoudi, Hossein Keshavarz
Format: Article
Language:English
Published: Taylor & Francis Group 2017-09-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
efficacy
rts
s/as01 malaria vaccine
vaccine development
Online Access:http://dx.doi.org/10.1080/21645515.2017.1295906

Similar Items

Similar Items